Clinical Trial Update: Safety and Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Children Receiving Solid Organ Transplants [Phase 3]

View source ↗

Summary

Phase 3 trial updating safety and immunogenicity of the 7-valent pneumococcal vaccine in pediatric solid organ transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Organ Transplant

Drugs mentioned

• 7-valent pneumococcal conjugate vaccine (pneumococcal conjugate vaccine, 7-valent)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Organ Transplant, Immunosuppression | Phase 3 | Status: COMPLETED